TWThomas N. Williams

Thomas N. Williams

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas N. Williams has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Sammy Wambua

    Pwani University Biosciences Research Centre (PUBReC), Pwani University

    5 shared publications
  • Kevin Marsh

    Kenya Medical Research Institute/Wellcome Trust Programme, Centre for Geographic Medicine Research Coast, Kilifi District Hospital, Kilifi, Kenya

    4 shared publications
  • Robert William Snow

    Population and Health Impact Surveillance Group, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya

    4 shared publications
  • Sophie Uyoga

    Department of Epidemiology and Demography Nairobi Nairobi County 254 KEMRI-Wellcome Trust Research Programme Nairobi

    4 shared publications
  • David J Weatherall

    Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, The University of Oxford, Oxford, United Kingdom

    3 shared publications
  • Moses Kortok

    Kenya Medical Research Institute/Wellcome Trust Programme, Centre for Geographic Medicine Research Coast, Kilifi District Hospital, Kilifi, Kenya

    3 shared publications

Latest Publications

  • Open Access

    The Effect of α +-Thalassaemia on the Incidence of Malaria and Other Diseases in Children Living on the Coast of Kenya

    by Sammy Wambua, Tabitha W Mwangi, Moses Kortok, Sophie M Uyoga, Alex W Macharia, Jedidah K Mwacharo, David J Weatherall, Robert W Snow, Kevin Marsh, Thomas N Williams

    The α-thalassaemias are the commonest genetic disorders of humans. It is generally believed that this high frequency reflects selection through a survival advantage against death from malaria; nevertheless, the epidemiological description of the relationships between α-thalassaemia, malaria, and other common causes of child mortality remains incomplete. We studied the α+-thalassaemia-specific incidence of malaria and other common childhood diseases in two cohorts of children living on the coast of Kenya. We found no associations between α+-thalassaemia and the prevalence of symptomless Plasmodium falciparum parasitaemia, the incidence of uncomplicated P. falciparum disease, or parasite densities during mild or severe malaria episodes. However, we found significant negative associations between α+-thalassaemia and the incidence rates of severe malaria and severe anaemia (haemoglobin concentration < 50 g/l). The strongest associations were for severe malaria anaemia (> 10,000 P. falciparum parasites/μl) and severe nonmalaria anaemia; the incidence rate ratios and 95% confidence intervals (CIs) for α+-thalassaemia heterozygotes and homozygotes combined compared to normal children were, for severe malaria anaemia, 0.33 (95% CI, 0.15,0.73; p = 0.006), and for severe nonmalaria anaemia, 0.26 (95% CI, 0.09,0.77; p = 0.015). Our observations suggest, first that selection for α+-thalassaemia might be mediated by a specific effect against severe anaemia, an observation that may lead to fresh insights into the aetiology of this important condition. Second, although α+-thalassaemia is strongly protective against severe and fatal malaria, its effects are not detectable at the level of any other malaria outcome; this result provides a cautionary example for studies aimed at testing malaria interventions or identifying new malaria-protective genes.


  • Open Access

    Co‐inheritance of α+‐thalassaemia and sickle trait results in specific effects on haematological parameters

    by Sammy Wambua, Jedidah Mwacharo, Sophie Uyoga, Alexander Macharia, Thomas N. Williams

    Both the sickle cell trait (HbAS) and α+‐thalassaemia are common in many tropical areas. While their individual haematological effects are well described, few studies describe their effects when inherited together. We present data from the Kenyan coast, which suggest that HbAS and α+‐thalassaemia may interact to produce specific effects on haematological parameters. Overall, the difference in Hb concentrations between non‐thalassaemics (αα/αα) and α+‐thalassaemia homozygotes (−α/−α) was greater in non‐HbAS (HbAA) (0·63 g/dl) than in HbAS children (0·25 g/dl). HbAS also ameliorated both the reduced mean cell volume and mean cell haemoglobin normally associated with the −α/−α genotype. Potential mechanisms and implications are discussed.


  • Negative epistasis between the malaria-protective effects of α+-thalassemia and the sickle cell trait

    by Thomas N Williams, Tabitha W Mwangi, Sammy Wambua, Timothy E A Peto, David J Weatherall, Sunetra Gupta, Mario Recker, Bridget S Penman, Sophie Uyoga, Alex Macharia, et al.

    The hemoglobinopathies, disorders of hemoglobin structure and production, protect against death from malaria1. In sub-Saharan Africa, two such conditions occur at particularly high frequencies: presence of the structural variant hemoglobin S and α+-thalassemia, a condition characterized by reduced production of the normal α-globin component of hemoglobin. Individually, each is protective against severe Plasmodium falciparum malaria2,3,4, but little is known about their malaria-protective effects when inherited in combination. We investigated this question by studying a population on the coast of Kenya and found that the protection afforded by each condition inherited alone was lost when the two conditions were inherited together, to such a degree that the incidence of both uncomplicated and severe P. falciparum malaria was close to baseline in children heterozygous with respect to the mutation underlying the hemoglobin S variant and homozygous with respect to the mutation underlying α+-thalassemia. Negative epistasis could explain the failure of α+-thalassemia to reach fixation in any population in sub-Saharan Africa.


  • Both heterozygous and homozygous α+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya

    by Thomas N. Williams, Sammy Wambua, Sophie Uyoga, Alex Macharia, Jedidah K. Mwacharo, Charles R. J. C. Newton, Kathryn Maitland

    Although the α+ thalassemias almost certainly confer protection against death from malaria, this has not been formally documented. We have conducted a study involving 655 case patients with rigorously defined severe malaria and 648 controls, frequency matched on area of residence and ethnic group. The prevalence of both heterozygous and homozygous α+ thalassemia was reduced in both case patients with severe malaria (adjusted odds ratios [ORs], 0.73 and 0.57; 95% confidence intervals [95% CIs], 0.57-0.94 and 0.40-0.81; P = .013 and P = .002, respectively, compared with controls) and among the subgroup of children who died after admission with severe malaria (OR, 0.60 and 0.37; 95% CI, 0.37-1.00 and 0.16-0.87; P = .05 and P = .02, respectively, compared with surviving case patients). The lowest ORs were seen for the forms of malaria associated with the highest mortality—coma and severe anemia complicated by deep, acidotic breathing. Our study supports the conclusion that both heterozygotes and homozygotes enjoy a selective advantage against death from Plasmodium falciparum malaria.


  • Top Cited Papers
    Open Access

    Sickle Cell Trait and the Risk ofPlasmodium falciparumMalaria and Other Childhood Diseases

    by Thomas N. Williams, Tabitha W. Mwangi, Sammy Wambua, Neal D. Alexander, Moses Kortok, Robert W. Snow, Kevin Marsh

    BackgroundThe gene for sickle hemoglobin (HbS) is a prime example of natural selection. It is generally believed that its current prevalence in many t


  • Open Access

    An Immune Basis for Malaria Protection by the Sickle Cell Trait

    by Thomas N Williams, Tabitha W Mwangi, David J Roberts, Neal D Alexander, David J Weatherall, Sammy Wambua, Moses Kortok, Robert W Snow, Kevin Marsh

    Malaria resistance by the sickle cell trait (genotype HbAS) has served as the prime example of genetic selection for over half a century. Nevertheless, the mechanism of this resistance remains the subject of considerable debate. While it probably involves innate factors such as the reduced ability of Plasmodium falciparum parasites to grow and multiply in HbAS erythrocytes, recent observations suggest that it might also involve the accelerated acquisition of malaria-specific immunity. We studied the age-specific protection afforded by HbAS against clinical malaria in children living on the coast of Kenya. We found that protection increased with age from only 20% in the first 2 y of life to a maximum of 56% by the age of 10 y, returning thereafter to 30% in participants greater than 10 y old. Our observations suggest that malaria protection by HbAS involves the enhancement of not only innate but also of acquired immunity to the parasite. A better understanding of the underlying mechanisms might yield important insights into both these processes.


  • Open Access

    Reevaluation of flow cytometry for investigating antibody binding to the surface of Plasmodium falciparum trophozoite‐infected red blood cells

    by T. N. Williams, C. I. Newbold

    Background The acquisition of antibodies directed toward variant surface antigens (VSAs) expressed on the surface of the trophozoite-infected red blood cell is an important determinant of natural immunity to Plasmodium falciparum malaria. In recent years, flow cytometry has been used increasingly to investigate these responses, but few systematic assessments of this method are available in the published literature. Methods We developed a highly standardized experimental protocol and used parasites of the A4 laboratory clone, a monoclonal antibody to the VSA expressed by this clone (monoclonal antibody BC6), and a single pool of hyperimmune plasma to explore the parameters responsible for variations in VSA antibody responses measured by flow cytometry. Results Despite strenuous efforts to standardize our flow cytometric assay, we found marked variability in our assay readout, even between repeat experiments using identical antibody and parasite combinations. We found no remediable cause for much of this variability. However, we identified three major factors that we considered important contributors: antibody concentration, nonspecific antibody binding to uninfected red blood cells, and parasite agglutination. Conclusions A number of potential pitfalls should be considered when designing and interpreting studies using this technique. In particular, we suggest that comparisons between assays conducted on different occasions can be made only through reference to carefully selected standards. We anticipate that a better appreciation of the factors that lead to assay variation will assist the design of improved experimental protocols. Cytometry Part A 56A:96–103, 2003.


  • The membrane characteristics of Plasmodium falciparum‐infected and ‐uninfected heterozygous α0thalassaemic erythrocytes

    by Thomas N. Williams, David J. Weatherall, Christopher I. Newbold

    Summary. The α thalassaemias are the commonest known human genetic disorders. Although they have almost certainly risen to their current frequencies through natural selection by malaria, the precise mechanism of malaria protection remains unknown. We have investigated the characteristics of red blood cells (RBCs) from individuals heterozygous for α0thalassaemia (–/αα) from a range of perspectives. On the basis of the hypothesis that defects in membrane transport could be relevant to the mechanism of malaria protection, we investigated sodium and potassium transport and the activity of the Plamodium falciparum‐induced choline channel but found no significant differences in –/αα RBCs. Using flow cytometry, we found that thalassaemic P. falciparum‐infected RBCs (IRBCs) bound 44% more antibody from immune plasma than control IRBCs. This excess binding was abrogated by predigestion of IRBCs with trypsin but was not directed at the variant surface molecule PfEMP1. Furthermore, we found no evidence for altered cytoadhesion of α‐thalassaemic IRBCs to the endothelial receptors intercellular adhesion molecule‐1 (ICAM‐1), CD36 or thrombospondin. We hypothesize that altered red‐cell membrane band 3 protein may be a target for enhanced antibody binding to α‐thalassaemic IRBCs and could be involved in the mechanism of malaria protection.